Cancer Family
Stromal Neoplasm
CI-CAN-00000360Explore in graph →
Non-malignant52 active trials2 approved drugs89 evidence items
- NCIt
- C6781
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000360Explore in graph →
Clinical trials
355 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00718562 | Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib | completed | Phase 2 | 35 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT02443948 | Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST) | unknown | — | 60 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Feb 14, 2017 |
| NCT00585221 | Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients | terminated | Phase 2 | 8 | University of UtahOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT00444795 | Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene | completed | — | 520 | PfizerINDUSTRY | 1 | Feb 1, 2017 | clinicaltrials |
| NCT01643278 | Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic | completed | Phase 1 | 29 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2017 | clinicaltrials |
| NCT01289028 | Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib. | completed | Phase 3 | 125 | Novartis PharmaceuticalsINDUSTRY | 2 | Jan 2, 2017 | clinicaltrials |
| NCT02488746 | Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST) | terminated | — | 5 | Kliniken Ludwigsburg-Bietigheim gGmbHOTHER | 1 | Dec 9, 2016 | clinicaltrials |
| NCT02150213 | Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 | completed | Phase 2 | 59 | Novartis PharmaceuticalsINDUSTRY | 6 | Dec 5, 2016 | clinicaltrials |
| NCT01483014 | Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)(CONVERT) | completed | Phase 2 | 30 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00897442 | Collecting Tumor Samples From Patients With Gynecological Tumors | completed | — | 275 | Gynecologic Oncology GroupNETWORK | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02931981 | Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor | unknown | — | 50 | RenJi HospitalOTHER | 1 | Oct 13, 2016 | clinicaltrials |
| NCT01404650 | Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor | completed | Phase 2 | 25 | SCRI Development Innovations, LLCOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT02877368 | Sarcopenia in Patients With Gastrointestinal Stromal Tumours(SARCO-GIST) | completed | — | 31 | CHU de ReimsOTHER | 1 | Aug 24, 2016 | clinicaltrials |
| NCT01689376 | Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program) | no longer available | — | — | BayerINDUSTRY | 0 | Aug 16, 2016 | clinicaltrials |
| NCT02866045 | EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs | unknown | Phase 3 | 104 | Unity Health TorontoOTHER | 1 | Aug 15, 2016 | clinicaltrials |
| NCT00767234 | Permission to Collect Blood Over Time for Research | terminated | — | 104 | Stanford UniversityOTHER | 1 | Jul 11, 2016 | clinicaltrials |
| NCT00785785 | A Study of Nilotinib Versus Imatinib in GIST Patients(ENESTg1) | completed | Phase 3 | 644 | Novartis PharmaceuticalsINDUSTRY | 35 | Jun 16, 2016 | clinicaltrials |
| NCT02776878 | A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST | unknown | N/A | 57 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 18, 2016 | clinicaltrials |
| NCT01478373 | Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib | completed | Phase 2 | 39 | Novartis PharmaceuticalsINDUSTRY | 5 | Apr 27, 2016 | clinicaltrials |
| NCT01462994 | Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST) | completed | Phase 3 | 25 | Technical University of MunichOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT01039519 | A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) | completed | Phase 2 | 27 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01323400 | Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)(PAZOGIST) | completed | Phase 2 | 81 | Centre Leon BerardOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT02662478 | Laparoscopic Resection of Large Gastric Stromal Tumors | completed | — | 23 | Medical Park Gaziantep HospitalOTHER | 0 | Feb 4, 2016 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02576080 | Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index(GIGIST) | unknown | Phase 3 | 80 | Assistance Publique Hopitaux De MarseilleOTHER | 0 | Oct 15, 2015 | clinicaltrials |
| NCT00618319 | An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST) | completed | Phase 2 | 20 | BiogenINDUSTRY | 1 | Oct 2, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00293124 | Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors | completed | Phase 3 | 125 | Central European Cooperative Oncology GroupOTHER | 10 | Aug 13, 2015 | clinicaltrials |
| NCT02426762 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | unknown | Phase 2 | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02268435 | Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors | withdrawn | Phase 1 | 0 | Asan Medical CenterOTHER | 0 | Aug 4, 2015 | clinicaltrials |
| NCT01613053 | Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination(MACS2226) | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 24, 2015 | clinicaltrials |
| NCT00030667 | Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01265979 | WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib | completed | — | 5 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT01389583 | A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients | unknown | Phase 2 | 25 | National Health Research Institutes, TaiwanOTHER | 1 | Feb 25, 2015 | clinicaltrials |
| NCT01267695 | Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor | completed | Phase 2 | 20 | Peking UniversityOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT02353052 | Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST | unknown | — | 900 | Shanghai Zhongshan HospitalOTHER | 1 | Feb 2, 2015 | clinicaltrials |
| NCT00009906 | Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor | terminated | Phase 3 | 748 | National Cancer Institute (NCI)NIH | 3 | Dec 23, 2014 | clinicaltrials |
| NCT01646593 | Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy | no longer available | — | — | BayerINDUSTRY | 0 | Dec 15, 2014 | clinicaltrials |
| NCT01751919 | A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I) | completed | Phase 1 | 37 | Dong-A ST Co., Ltd.INDUSTRY | 1 | Oct 1, 2014 | clinicaltrials |
| NCT02246322 | A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions.(EUS-FNA) | unknown | N/A | 144 | Istituto Clinico HumanitasOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT00237185 | A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene | completed | Phase 2 | 148 | Novartis PharmaceuticalsINDUSTRY | 3 | Aug 19, 2014 | clinicaltrials |
| NCT00685828 | Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor | unknown | Phase 3 | 946 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Jul 4, 2014 | clinicaltrials |
| NCT02103322 | Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions | completed | Phase 2 / Phase 3 | 48 | Amneal Pharmaceuticals, LLCINDUSTRY | 1 | Jun 27, 2014 | clinicaltrials |
| NCT01381822 | Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors(TH-CR-410) | unknown | Phase 1 | 58 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 21, 2014 | clinicaltrials |
| NCT00751036 | Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg(MACS0375) | terminated | Phase 3 | 94 | Novartis PharmaceuticalsINDUSTRY | 9 | Mar 26, 2014 | clinicaltrials |
| NCT01421680 | The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients | completed | N/A | 144 | Seoul National University HospitalOTHER | 1 | Mar 14, 2014 | clinicaltrials |
| NCT00254267 | Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors | completed | Phase 2 | 35 | AmgenINDUSTRY | 0 | Feb 27, 2014 | clinicaltrials |
| NCT00367861 | Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance | completed | Phase 3 | 564 | Centre Leon BerardOTHER | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00399152 | Perifosine + Sunitinib Malate for Patients With Advanced Cancers | completed | Phase 1 | 15 | AEterna ZentarisINDUSTRY | 0 | Feb 19, 2014 | clinicaltrials |
| NCT01227746 | A Retrospective Study of C-kit Mutation Status in Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib. | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Jan 22, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Feb 23, 2017source: clinicaltrials